Literature DB >> 26649859

Premixed insulin regimens for type 2 diabetes.

Apostolos Tsapas1,2,3, Thomas Karagiannis4, Eleni Bekiari4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26649859     DOI： 10.1007/s12020-015-0821-5

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  19 in total

1.  Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UK.

Authors:  W J Valentine; B H Curtis; R F Pollock; K Van Brunt; R Paczkowski; M Brändle; K S Boye; D M Kendall
Journal:  Diabetes Res Clin Pract       Date:  2015-04-21       Impact factor: 5.602

2.  Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in Canada.

Authors:  Sandra L Tunis; Luc Sauriol; Michael E Minshall
Journal:  Appl Health Econ Health Policy       Date:  2010       Impact factor: 2.561

3.  A retrospective database study of insulin initiation in patients with Type 2 diabetes in UK primary care.

Authors:  B T Blak; H T Smith; M Hards; A Maguire; V Gimeno
Journal:  Diabet Med       Date:  2012-08       Impact factor: 4.359

4.  Switching from premixed insulin to basal-bolus insulin glargine plus rapid-acting insulin: the ATLANTIC study.

Authors:  C Mathieu; F Storms; J Tits; T F Veneman; I M Colin
Journal:  Acta Clin Belg       Date:  2013 Jan-Feb       Impact factor: 1.264

5.  Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2015-01       Impact factor: 19.112

Review 6.  Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

Authors:  C Wang; J Mamza; I Idris
Journal:  Diabet Med       Date:  2015-02-13       Impact factor: 4.359

Review 7.  A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus--a systematic review and meta-analysis.

Authors:  P Rys; P Wojciechowski; S Siejka; P Małecki; L Hak; M T Malecki
Journal:  Int J Clin Pract       Date:  2014-01-28       Impact factor: 2.503

8.  Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study.

Authors:  M Peyrot; A H Barnett; L F Meneghini; P-M Schumm-Draeger
Journal:  Diabet Med       Date:  2012-05       Impact factor: 4.359

Review 9.  Intensification of insulin therapy for type 2 diabetic patients in primary care: basal-bolus regimen versus premix insulin analogs: when and for whom?

Authors:  Ofri Mosenzon; Itamar Raz
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

Review 10.  Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review.

Authors:  Hilary I Price; Meghan D Agnew; John-Michael Gamble
Journal:  BMJ Open       Date:  2015-03-11       Impact factor: 2.692
View more
  1 in total

1.  Premixed insulin regimens in type 2 diabetes: pros.

Authors:  Maria Ida Maiorino; Giuseppe Bellastella; Katherine Esposito; Dario Giugliano
Journal:  Endocrine       Date:  2016-03-22       Impact factor: 3.633
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.